Eli Lilly and Company: all 2,262 studies
Page 7 of 23. Open to participants first (177), then studies with results posted, then the rest; newest registration first within each.
- A Study of Galcanezumab in Healthy Participants.CompletedNCT02836613Phase 1Results posted
- A Study of LY3039478 in Japanese Participants With Advanced Solid TumorsCompletedNCT02836600Phase 1Results posted
- A Study of Single or Repeated Doses of Glucagon in Participants With DiabetesCompletedNCT02806973Phase 1Results posted
- A Study of Single and Repeated Doses of Glucagon Administered to Participants With DiabetesTerminatedNCT02806960Phase 1Results posted
- A Study of LY2951742 (Galcanezumab) in Participants With Cluster HeadacheCompletedNCT02797951Phase 3Results posted
- Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05CompletedNCT02795780Phase 2Results posted
- A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease DementiaTerminatedNCT02791191Phase 2Results posted
- A Study of Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung CancerCompletedNCT02789345Phase 1Results posted
- A Study of LY3039478 in Participants With Advanced or Metastatic Solid TumorsTerminatedNCT02784795Phase 1Results posted
- A Study of Olaratumab (LY3012207) in Participants With Soft Tissue SarcomaCompletedNCT02783599Phase 1Results posted
- A Study of Glucagon Administered in Different Forms and Routes to Healthy AdultsCompletedNCT02778113Phase 1Results posted
- A Study of Nasal Glucagon in Participants With a Common ColdCompletedNCT02778100Phase 1Results posted
- A Study of Treprostinil and a New Formulation of LY900014 in Healthy Japanese ParticipantsCompletedNCT02770521Phase 1Results posted
- Biomarker Study in Participants With MigraineCompletedNCT02766517Early Phase 1Results posted
- A Study of Abemaciclib (LY2835219) in Participants With Breast CancerActive, not recruitingNCT02763566Phase 3Results posted
- A Study of Solanezumab (LY2062430) in Participants With Prodromal Alzheimer's DiseaseTerminatedNCT02760602Phase 3Results posted
- A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)CompletedNCT02759107Phase 1Results posted
- A Study of Baricitinib (LY3009104) in Healthy Chinese ParticipantsCompletedNCT02758613Phase 1Results posted
- A Study of Ixekizumab (LY2439821) in Participants With Nonradiographic Axial SpondyloarthritisCompletedNCT02757352Phase 3Results posted
- A Study of LY3303560 in Healthy Participants and Participants With Alzheimer's Disease (AD)CompletedNCT02754830Phase 1Results posted
- A Study to Compare the Effects of a Test and Reference Formulation of LY900014 in Healthy ParticipantsCompletedNCT02752087Phase 1Results posted
- A Study of Dulaglutide in Japanese Participants With Type 2 DiabetesCompletedNCT02750410Phase 4Results posted
- A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast CancerCompletedNCT02747004Phase 2Results posted
- A Study of LY2510924 and Durvalumab in Participants With Solid TumorsTerminatedNCT02737072Phase 1Results posted
- A Study of Prexasertib (LY2606368) in Participants With Extensive Stage Disease Small Cell Lung CancerCompletedNCT02735980Phase 2Results posted
- A Study of LY3022855 in Combination With Durvalumab or Tremelimumab in Participants With Advanced Solid TumorsCompletedNCT02718911Phase 1Results posted
- A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Genital PsoriasisCompletedNCT02718898Phase 3Results posted
- A Study to Evaluate LY3202328 in Overweight Healthy Participants and DyslipidemiaCompletedNCT02714569Phase 1Results posted
- A Study of Ramucirumab (LY3009806) or Merestinib (LY2801653) in Advanced or Metastatic Biliary Tract CancerActive, not recruitingNCT02711553Phase 2Results posted
- A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE)CompletedNCT02708095Phase 2Results posted
- A Study of LY900014 in Participants With Type 1 Diabetes on Insulin Injection TherapyCompletedNCT02703350Phase 1Results posted
- A Study of LY900014 in Participants With Type 2 Diabetes on Insulin Injection TherapyCompletedNCT02703337Phase 1Results posted
- A Study of LY900014 Formulation in Participants With Type 1 Diabetes Mellitus Using Insulin PumpsCompletedNCT02703324Phase 1Results posted
- A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial SpondyloarthritisCompletedNCT02696798Phase 3Results posted
- A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial SpondyloarthritisCompletedNCT02696785Phase 3Results posted
- A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the BodyCompletedNCT02688088Phase 1Results posted
- A Study of Abemaciclib in Healthy ParticipantsCompletedNCT02677844Phase 1Results posted
- A Study of Olaratumab Alone and in Combination With Standard Chemotherapies in Children With CancerCompletedNCT02677116Phase 1Results posted
- A Study of Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast CancerCompletedNCT02675231Phase 2Results posted
- A Study of Abemaciclib in Healthy ParticipantsCompletedNCT02672423Phase 1Results posted
- A Study of LY3039478 in Healthy ParticipantsCompletedNCT02659865Phase 1Results posted
- A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue SarcomaCompletedNCT02659020Phase 1/2Results posted
- A Study of Various Formulations of LY900014 in Healthy ParticipantsCompletedNCT02636361Phase 1Results posted
- A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque Psoriasis Naive to Systemic TreatmentCompletedNCT02634801Phase 3Results posted
- A Study of LY3337641 in Rheumatoid ArthritisTerminatedNCT02628028Phase 2Results posted
- A Study of LY3002813 in Participants With Memory Damage Due to Alzheimer's Disease (AD) or ADCompletedNCT02624778Phase 1Results posted
- A Safety Study of Galcanezumab in Participants With Migraine, With or Without AuraCompletedNCT02614287Phase 3Results posted
- Evaluation of Galcanezumab in the Prevention of Chronic MigraineCompletedNCT02614261Phase 3Results posted
- Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 StudyCompletedNCT02614196Phase 3Results posted
- Evaluation of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-1 StudyCompletedNCT02614183Phase 3Results posted
- A Study of LY2599666 in Healthy Participants and Participants With Mild Cognitive Impairment or Alzheimer's Disease (AD)TerminatedNCT02614131Phase 1Results posted
- Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of MigraineCompletedNCT02605174Phase 3Results posted
- A Study of LY3113593 in Participants With Chronic Kidney DiseaseCompletedNCT02604160Phase 1Results posted
- A Study of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes MellitusCompletedNCT02597049Phase 3Results posted
- A Study of LY3127804 With Ramucirumab in Participants With Advanced Solid TumorsTerminatedNCT02597036Phase 1Results posted
- A Study of Mirikizumab (LY3074828) in Participants With Moderate to Severe Ulcerative ColitisCompletedNCT02589665Phase 2Results posted
- A Study of U-500 Insulin (LY041001) in Participants With Type 2 DiabetesTerminatedNCT02588950Phase 1Results posted
- A Long-Term Efficacy and Safety Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisCompletedNCT02584855Phase 3Results posted
- A Study of Galcanezumab in Healthy ParticipantsCompletedNCT02576951Phase 1Results posted
- A Study of Baricitinib (LY3009104) in Participants With Moderate-to-Severe Atopic DermatitisCompletedNCT02576938Phase 2Results posted
- A Study of Mirikizumab (LY3074828) in Healthy ParticipantsCompletedNCT02568423Phase 1Results posted
- An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of MigraineCompletedNCT02565186Phase 3Results posted
- A Study of Ramucirumab (LY3009806) in Children With Refractory Solid TumorsCompletedNCT02564198Phase 1Results posted
- A Study of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsoriasisCompletedNCT02561806Phase 3Results posted
- An Administration Method Study of Human Regular U-500 Insulin (LY041001) in Participants With Type 2 Diabetes MellitusCompletedNCT02561078Phase 3Results posted
- A Study of [¹⁴C]-LY3202626 in Healthy Male ParticipantsCompletedNCT02555449Phase 1Results posted
- A Study of the Immune Response to Vaccines and Ixekizumab (LY2439821) in Healthy ParticipantsCompletedNCT02543918Phase 1Results posted
- A Study of Ramucirumab in Participants With Gastric or Gastroesophageal Junction AdenocarcinomaCompletedNCT02539225Phase 2Results posted
- A Study of LY3076226 in Participants With Advanced or Metastatic CancerCompletedNCT02529553Phase 1Results posted
- A Study of a New LY900014 Formulation in Healthy ParticipantsCompletedNCT02525744Phase 1Results posted
- A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBLCompletedNCT02518113Phase 1/2Results posted
- 18F-AV-1451 Autopsy StudyCompletedNCT02516046Phase 3Results posted
- A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric CancerCompletedNCT02514551Phase 2Results posted
- A Study Comparing Different Dosing Regimens of Ixekizumab (LY2439821) in Participants With Moderate to Severe Plaque PsoriasisCompletedNCT02513550Phase 3Results posted
- A Study of Different Particle Sizes of Evacetrapib in Healthy ParticipantsCompletedNCT02497391Phase 1Results posted
- A Study of Cephalexin Liquid in Healthy ParticipantsCompletedNCT02490670Phase 1Results posted
- A Study of Abemaciclib (LY2835219) in Healthy Participants With and Without FoodCompletedNCT02482935Phase 1Results posted
- A Study of Doxorubicin Plus Olaratumab (LY3012207) in Participants With Advanced or Metastatic Soft Tissue SarcomaCompletedNCT02451943Phase 3Results posted
- A Study of the Combination of Necitumumab (LY3012211) and Pembrolizumab (MK3475) in Participants With NSCLCCompletedNCT02451930Phase 1Results posted
- A Study of Abemaciclib (LY2835219) in Participants With Stage IV Squamous Non-small Cell Lung CancerCompletedNCT02450539Phase 2Results posted
- A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) CancerCompletedNCT02443883Phase 2Results posted
- A Study of LY3023414 and Necitumumab in Squamous Lung CancerTerminatedNCT02443337Phase 2Results posted
- A Study of Ramucirumab Plus Pembrolizumab in Participants With Gastric or GEJ Adenocarcinoma, NSCLC, Transitional Cell Carcinoma of the Urothelium, or Biliary Tract CancerCompletedNCT02443324Phase 1Results posted
- A Neoadjuvant Study of Abemaciclib (LY2835219) in Postmenopausal Women With Hormone Receptor Positive, HER2 Negative Breast CancerCompletedNCT02441946Phase 2Results posted
- Lasmiditan Compared to Placebo in the Acute Treatment of Migraine:CompletedNCT02439320Phase 3Results posted
- A Study of Galcanezumab in Participants With Chronic Cluster HeadacheCompletedNCT02438826Phase 3Results posted
- A Study of Ramucirumab (LY3009806) Versus Placebo in Participants With Hepatocellular Carcinoma and Elevated Baseline Alpha-FetoproteinCompletedNCT02435433Phase 3Results posted
- A Study of Tadalafil (LY450190) in Participants With Lower Urinary Tract Symptoms (LUTS) Suggestive of Benign Prostatic Hyperplasia LUTS (BPH-LUTS).CompletedNCT02431754Phase 4Results posted
- A Dose-ranging Study of DRM01 in Subjects With Acne VulgarisCompletedNCT02431052Phase 2Results posted
- A Study of Ramucirumab (LY3009806) Plus Docetaxel in Participants With Urothelial CancerCompletedNCT02426125Phase 3Results posted
- A Study of Galunisertib (LY2157299) in Combination With Nivolumab in Advanced Refractory Solid Tumors and in Recurrent or Refractory NSCLC, or Hepatocellular CarcinomaCompletedNCT02423343Phase 1/2Results posted
- A Study of Duloxetine (LY248686) in Participants With Diabetic Peripheral Neuropathic Pain (DPNP)CompletedNCT02417935Phase 4Results posted
- A Study of Necitumumab and Abemaciclib in Participants With Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02411591Phase 1Results posted
- A Study of Ramucirumab (LY3009806) in Combination With Erlotinib in Previously Untreated Participants With EGFR Mutation-Positive Metastatic NSCLC (RELAY)Active, not recruitingNCT02411448Phase 3Results posted
- A Study of Enzalutamide and LY3023414 in Men With Prostate CancerCompletedNCT02407054Phase 2Results posted
- Clinical Usability of Nasal Glucagon in Treatment of Hypoglycemia in Children and AdolescentsCompletedNCT02402933Phase 3Results posted
- A Study Of Galcanezumab In Participants With Episodic Cluster HeadacheCompletedNCT02397473Phase 3Results posted
- A Study of Nab-Paclitaxel and Carboplatin Plus Necitumumab (LY3012211) in Participants With Stage IV Squamous NSCLCCompletedNCT02392507Phase 2Results posted
- A Study of Abemaciclib in Participants With Varying Degrees of Liver ImpairmentCompletedNCT02387814Phase 1Results posted
- A Study of the Early Activity of Ixekizumab (LY2439821) in Moderate-to-Severe PsoriasisCompletedNCT02387801Phase 3Results posted